Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids

European Heart Journal

Volumn 18, Issue 2, 1997, Pages 235-241

  Mitropoulos, K A ^a   Armitage, J M ^a   Collins, R ^a   Meade, T W ^a   Reeves, B E A ^a   Wallendszus, K R ^a   Wilson, S S ^a   Lawson, A ^a   Peto, R ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Fatty acids; Haemostatic variables; Randomized trial; Simvastatin

Indexed keywords

ANTILIPEMIC AGENT; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; CHOLESTEROL; FATTY ACID; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR; PROTHROMBIN; SIMVASTATIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FATTY ACID BLOOD LEVEL; FEMALE; HEMOSTASIS; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOGENESIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031020585     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.eurheartj.a015225     Document Type: Article

References (34)